Lactobacillus iners and genital health: molecular clues to an enigmatic vaginal species
- PMID: 37234911
- PMCID: PMC10209668
- DOI: 10.1007/s11908-023-00798-5
Lactobacillus iners and genital health: molecular clues to an enigmatic vaginal species
Abstract
Purpose of review: Vaginal lactobacilli are recognized as important drivers of genital health including protection against bacterial vaginosis and sexually transmitted infections. Lactobacillus iners is distinct from L. crispatus, L. gasseri, and L. jensenii by its high global prevalence in vaginal microbiomes, relatively small genome, production of only L-lactic acid, and inconsistent associations with genital health outcomes. In this review, we summarize our current understanding of the role of L. iners in the vaginal microbiome, highlight the importance of strain-level consideration for this species, and explain that while marker gene-based characterization of the composition of the vaginal microbiota does not capture strain-level resolution, whole metagenome sequencing can aid in expanding our understanding of this species in genital health.
Recent findings: L. iners exists in the vaginal microbiome as a unique combination of strains. The functional repertoires of these strain combinations are likely wide and contribute to the survival of this species in a variety of vaginal microenvironments. In published studies to date, strain-specific effects are aggregated and may yield imprecise estimates of risk associated with this species.
Summary: The worldwide high prevalence of Lactobacillus iners warrants more research into its functional roles in the vaginal microbiome and how it may directly impact susceptibility to infections. By incorporating strain-level resolution into future research endeavors, we may begin to appreciate L. iners more thoroughly and identify novel therapeutic targets for a variety of genital health challenges.
Keywords: Lactobacillus iners; bacterial vaginosis; metagenome; sexually transmitted infections; transcriptome; vaginal microbiome.
Conflict of interest statement
Conflict of Interest JR is co-founder of LUCA Biologics, a biotechnology company focusing on translating microbiome research into live biotherapeutics drugs for women’s health. Dr. Holm reports personal fees from Intralytix Inc., outside the submitted work. All other authors declare that they have no competing interests.
Figures


Similar articles
-
Practical media formulations for rapid growth of Lactobacillus iners and other vaginal bacteria.Appl Environ Microbiol. 2025 Aug 20;91(8):e0018325. doi: 10.1128/aem.00183-25. Epub 2025 Jul 8. Appl Environ Microbiol. 2025. PMID: 40626727 Free PMC article.
-
Contribution of Lactobacillus iners to Vaginal Health and Diseases: A Systematic Review.Front Cell Infect Microbiol. 2021 Nov 22;11:792787. doi: 10.3389/fcimb.2021.792787. eCollection 2021. Front Cell Infect Microbiol. 2021. PMID: 34881196 Free PMC article.
-
Effect of the vaginal live biotherapeutic LACTIN-V (Lactobacillus crispatus CTV-05) on vaginal microbiota and genital tract inflammation among women at high risk of HIV acquisition in South Africa: a phase 2, randomised, placebo-controlled trial.Lancet Microbe. 2025 Jun;6(6):101037. doi: 10.1016/j.lanmic.2024.101037. Epub 2025 Apr 4. Lancet Microbe. 2025. PMID: 40194532 Free PMC article. Clinical Trial.
-
Alleviative Effect of Vaginal Lactobacilli with Probiotic Potential from Healthy Chinese Women on Bacterial Vaginosis Caused by Gardnerella vaginalis in Mice.Probiotics Antimicrob Proteins. 2025 Jul 24. doi: 10.1007/s12602-025-10657-5. Online ahead of print. Probiotics Antimicrob Proteins. 2025. PMID: 40705233
-
Gender differences in the context of interventions for improving health literacy in migrants: a qualitative evidence synthesis.Cochrane Database Syst Rev. 2024 Dec 12;12(12):CD013302. doi: 10.1002/14651858.CD013302.pub2. Cochrane Database Syst Rev. 2024. PMID: 39665382
Cited by
-
Uterine fibroids and longitudinal profiles of the vaginal microbiota in a cohort presenting for transvaginal ultrasound.PLoS One. 2024 Feb 5;19(2):e0296346. doi: 10.1371/journal.pone.0296346. eCollection 2024. PLoS One. 2024. PMID: 38315688 Free PMC article.
-
Metagenome-validated combined amplicon sequencing and text mining-based annotations for simultaneous profiling of bacteria and fungi: vaginal microbiota and mycobiota in healthy women.Microbiome. 2024 Dec 28;12(1):273. doi: 10.1186/s40168-024-01993-9. Microbiome. 2024. PMID: 39731160 Free PMC article.
-
Sexual transmission of urogenital bacteria: whole metagenome sequencing evidence from a sexual network study.mSphere. 2024 Mar 26;9(3):e0003024. doi: 10.1128/msphere.00030-24. Epub 2024 Feb 15. mSphere. 2024. PMID: 38358269 Free PMC article.
-
Beyond hormones: 3PM approach to vaginal microbiota dynamics in postmenopausal women.EPMA J. 2025 Apr 15;16(2):299-350. doi: 10.1007/s13167-025-00406-7. eCollection 2025 Jun. EPMA J. 2025. PMID: 40438491 Review.
-
Bacterial vaginosis.Nat Rev Dis Primers. 2025 Jun 19;11(1):43. doi: 10.1038/s41572-025-00626-1. Nat Rev Dis Primers. 2025. PMID: 40537474 Review.
References
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials